
The director acquired 1,600 shares at $63.14 per share, representing a total capital commitment of ~$101,000 on July 31, 2026.
This transaction established a new direct equity position of 1,600 shares for the insider.
The purchase was executed directly by the reporting owner with no reported indirect holdings through trusts or other entities.
This acquisition occurred as the stock was priced at $62.00 at the July 31, 2026 market close, following a 32% decline in share value over the preceding 12 months.
Peter R. Lane, Director at Goosehead Insurance, Inc. (NASDAQ:GSHD), reported a direct purchase of 1,600 shares of Class A Common Stock on July 31, 2026. SEC Form 4 filing
| Metric | Value |
|---|---|
| Shares purchased | 1,600 |
| Transaction value | $101,024 |
| Post-transaction shares (directly held) | 1,600 |
| Post-transaction value | $99,200.00 |
Transaction value based on SEC Form 4 weighted average purchase price ($63.14); post-transaction value based on July 31, 2026, market close ($62.00).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-03) | $65.66 |
| Market Capitalization | $2.5 billion |
| Revenue (TTM) | $402.2 million |
| Net Income (TTM) | $42.2 million |
Goosehead Insurance operates as a leading personal lines insurance brokerage platform with a $2.5 billion market capitalization and TTM revenue of $402.2 million. The company's differentiated business model combines direct corporate operations with a scalable franchise network, enabling efficient market penetration and revenue growth. Goosehead's competitive positioning is strengthened by its technology-enabled platform, diverse product offerings, and dual-channel distribution strategy, which together constitute a significant competitive advantage in the fragmented insurance brokerage market.
Peter R. Lane, an executive at Goosehead Insurance (GSHD), recently reported a direct purchase of 1,600 shares of company stock. Here’s what it means for investors.
To start, it’s important to discuss why this insider transaction is slightly different from many others. Most notably, this is a purchase of shares rather than a sale. As is often said, insiders sell for many reasons, but they buy for only one. Namely, that they believe the stock is undervalued.
With that in mind, let’s take a closer look at Goosehead stock. Since 2021, the company’s shares have performed poorly. All in all, shares have generated a total return of -41%, with a compound annual growth rate (CAGR) of -10.0%. During the same period, the S&P 500 has delivered an 86% total return, with a 13.3% CAGR.
Over the last three years, Goosehead has averaged nearly 19% year-over-year revenue growth, with total revenue surging from around $250 million to more than $400 million. Despite this massive growth in sales, some could argue that the valuation remains expensive. The company’s price-to-earnings (P/E) multiple stands at 49x. While that is down significantly from a multiple of over 160x in late 2024, it remains quite high for the insurance sector, where P/E ratios are often in the low double-digits.
In summary, value-based investors may not find what they’re looking for in Goosehead. However, other investors, less concerned with valuation, may find the company’s history of steady double-digit revenue growth intriguing, particularly when combined with the insider purchase noted earlier.
Jake Lerch has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.